Clinical trial Recruiting at 2 sites Phase 3 Interventional Ages 18 and up

Combining virtual reality and brain stimulation to improve hand function after stroke

Official title: Investigating the Efficacy of Combining Virtual Reality-Based Mirror Therapy and Transcranial Direct Current Stimulation to Improve Upper Limb Recovery in Patients with Stroke

Run by King Saud University · NCT06764797 · Data updated 2026-11-12

This study is testing if using virtual reality and brain stimulation together can help stroke patients improve their hand function better than just regular therapy alone.

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorKing Saud University
Academic / other
Locations2 sites (Riyadh, Riyadh Region and 1 other locations)
StatusRecruiting
StartedSeptember 19, 2023
Main results expectedMay 31, 2025
Study endsJuly 21, 2025
Registry record updatedJanuary 8, 2025
Trial IDNCT06764797 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have experienced a stroke with moderate-to-severe arm impairment more than three months prior.

Probably not a fit

Patients with visual impairments, severe cognitive difficulties, or other neurological conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of combining virtual reality-based mirror therapy (VRMT) and transcranial direct current stimulation (tDCS) with conventional physical therapy (CPT) to enhance upper limb recovery in stroke patients. Participants will be randomly assigned to one of four groups to assess the impact of these interventions on hand function. The study aims to determine if the combination of VRMT and tDCS provides greater benefits than using either intervention alone. Functional scales will be utilized to evaluate improvements before and after the treatment.

Why it matters

Potential benefit: If successful, this approach could significantly enhance hand function and independence for stroke survivors.

How similar studies have gone: While the individual components of VRMT and tDCS have been explored, the combination approach in this context is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* At least 18 years old.
* Stroke patients with unilateral cerebral infarction or hemorrhage, more than three months following the stroke.
* Adequate cognitive ability to follow instructions (The Arabic version of the Mini-Mental State Examination scores \> 24).
* Modified Ashworth scale score \< 3.
* Fugl-Meyer Assessment (FMA) score of 10-58 indicating moderate-to-severe arm impairment.

Exclusion Criteria:

* visual impairment and field defect or hemi-sensory inattention and unilateral neglect.
* Wernicke's aphasia, or global aphasia, leads to difficulty following instructions.
* Any contraindication to NIBS.
* Other neurological conditions or participation in another study.

Where it's running

  • King fahad medical city
    Riyadh, Riyadh Region, Saudi Arabia
    Recruiting
  • King Khalid University Hospital
    Riyadh, Riyadh Region, Saudi Arabia
    Recruiting

Study contacts

  • Principal investigator: Alaa M. Albishi, Doctor of Philosophy — King Saud University
  • Study coordinator: Dr. Alaa M. Albishi, Assistant Professor
  • Email: aalbeshi@ksu.edu.sa
  • Phone: +966555090015

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.